Cancer Science & Therapy

Song Xin

Song Xin, PhD
Professor
Kunming Medical University, Tumor Biotherapy Center, China

Biography

Song Xin is working as a Professor in the third affiliated hospital, Kunming Medical College, Kunming, China.

Research Interest

Signal transduction, Cell Cycle Biochemotherapy and  Molecular Carcinogenesis. Preclinical/clinical development of molecularly targeted cancer therapeutic agents and signaling networks, including molecular mechanism studies in vitro and in vivo of therapeutic agents and molecular carcinogenesis. Current research mainly focuses on investigation of the molecular and signaling transduction pathways.  Most agents are the regulators of signal transduction, cell cycle, apoptosis, angiogenesis, metastasis, differentiation, proteasome inhibition and DNA damage. Signal transduction including post translational modifications (acetylation, methylation, phosphorylation, cleavage) and molecular biologic events. The main signal transduction pathways he has studied are Ras/Raf/MEK/Erk, PKC/MAPK, PI3K/PKB/GSK3, NFk-B, PKA, proteasome, differentiation, cell cycle, caspase, cell death receptor, cell growth receptor, etc.